- Home
- FSTR vs RAPT Comparison
FSTR vs RAPT Comparison
Compare FSTR & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- RAPT
- Stock Information
- Founded
- FSTR 1902
- RAPT 2015
- Country
- FSTR United States
- RAPT United States
- Employees
- FSTR N/A
- RAPT N/A
- Industry
- FSTR Metal Fabrications
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- RAPT Health Care
- Exchange
- FSTR Nasdaq
- RAPT Nasdaq
- Market Cap
- FSTR 239.1M
- RAPT 194.2M
- IPO Year
- FSTR N/A
- RAPT 2019
- Fundamental
- Price
- FSTR $27.19
- RAPT $13.28
- Analyst Decision
- FSTR Hold
- RAPT Buy
- Analyst Count
- FSTR 1
- RAPT 5
- Target Price
- FSTR $25.00
- RAPT $33.60
- AVG Volume (30 Days)
- FSTR 38.3K
- RAPT 117.5K
- Earning Date
- FSTR 11-06-2025
- RAPT 08-07-2025
- Dividend Yield
- FSTR N/A
- RAPT N/A
- EPS Growth
- FSTR 395.33
- RAPT N/A
- EPS
- FSTR 3.32
- RAPT N/A
- Revenue
- FSTR $506,999,000.00
- RAPT N/A
- Revenue This Year
- FSTR $4.25
- RAPT N/A
- Revenue Next Year
- FSTR $3.61
- RAPT N/A
- P/E Ratio
- FSTR $8.00
- RAPT N/A
- Revenue Growth
- FSTR N/A
- RAPT N/A
- 52 Week Low
- FSTR $17.16
- RAPT $5.67
- 52 Week High
- FSTR $29.78
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- FSTR 64.58
- RAPT 64.67
- Support Level
- FSTR $26.16
- RAPT $11.19
- Resistance Level
- FSTR $27.37
- RAPT $13.66
- Average True Range (ATR)
- FSTR 0.96
- RAPT 0.82
- MACD
- FSTR 0.27
- RAPT 0.18
- Stochastic Oscillator
- FSTR 96.44
- RAPT 89.44
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.